239 related articles for article (PubMed ID: 23866765)
1. The consequence of undertreatment of patients treated with breast conserving therapy for ductal carcinoma in-situ.
Lee DY; Lewis JL; Wexelman BA; Freedman BC; Ross RE; Tartter PI
Am J Surg; 2013 Nov; 206(5):790-7. PubMed ID: 23866765
[TBL] [Abstract][Full Text] [Related]
2. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
3. A review of the management of ductal carcinoma in situ following breast conserving surgery.
Boxer MM; Delaney GP; Chua BH
Breast; 2013 Dec; 22(6):1019-25. PubMed ID: 24070852
[TBL] [Abstract][Full Text] [Related]
4. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].
Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B
Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020
[TBL] [Abstract][Full Text] [Related]
5. Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases.
Cutuli B; Lemanski C; Le Blanc-Onfroy M; de Lafontan B; Cohen-Solal-Le-Nir C; Fondrinier E; Mignotte H; Giard S; Charra-Brunaud C; Auvray H; Gonzague-Casabianca L; Quétin P; Fay R
Cancer Radiother; 2013 Jun; 17(3):196-201. PubMed ID: 23538041
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
[TBL] [Abstract][Full Text] [Related]
7. Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences.
Cutuli B; Wiezzane N; Palumbo I; Barbieri P; Guenzi M; Huscher A; Borghesi S; Delva C; Iannone T; Vianello E; Rosetto ME; Aristei C
Cancer Radiother; 2016 Jun; 20(4):292-8. PubMed ID: 27344537
[TBL] [Abstract][Full Text] [Related]
8. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
9. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
[TBL] [Abstract][Full Text] [Related]
11. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.
Habel LA; Achacoso NS; Haque R; Nekhlyudov L; Fletcher SW; Schnitt SJ; Collins LC; Geiger AM; Puligandla B; Acton L; Quesenberry CP
Breast Cancer Res; 2009; 11(6):R85. PubMed ID: 19922614
[TBL] [Abstract][Full Text] [Related]
12. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
[TBL] [Abstract][Full Text] [Related]
14. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
[TBL] [Abstract][Full Text] [Related]
15. Influence of local treatment on the recurrence rate of ductal carcinoma in situ.
Warneke J; Grossklaus D; Davis J; Stea B; Bebb G; Taylor C; Hastings R; Villar H
J Am Coll Surg; 1995 Jun; 180(6):683-8. PubMed ID: 7773481
[TBL] [Abstract][Full Text] [Related]
16. The value of the Van Nuys Prognostic Index in ductal carcinoma in situ of the breast: a retrospective analysis.
Asjoe FT; Altintas S; Huizing MT; Colpaert C; Marck EV; Vermorken JB; Tjalma WA
Breast J; 2007; 13(4):359-67. PubMed ID: 17593040
[TBL] [Abstract][Full Text] [Related]
17. The receptor expression pattern in ductal carcinoma in situ predicts recurrence.
Kepple J; Henry-Tillman RS; Klimberg VS; Layeeque R; Siegel E; Westbrook K; Korourian S
Am J Surg; 2006 Jul; 192(1):68-71. PubMed ID: 16769278
[TBL] [Abstract][Full Text] [Related]
18. Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ.
Liberman L; Van Zee KJ; Dershaw DD; Morris EA; Abramson AF; Samli B
AJR Am J Roentgenol; 1997 Feb; 168(2):489-93. PubMed ID: 9016233
[TBL] [Abstract][Full Text] [Related]
19. Pattern of local recurrence after conservative surgery and whole-breast irradiation.
Freedman GM; Anderson PR; Hanlon AL; Eisenberg DF; Nicolaou N
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1328-36. PubMed ID: 15817334
[TBL] [Abstract][Full Text] [Related]
20. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
